{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00670592: Phase 1/Phase 2 Interventional Completed Non-Hodgkin's Lymphoma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tenatumomab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01110720: Phase 2/Phase 3 Interventional Completed Progressive Supranuclear Palsy
(2010)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
FERTIRELIN is an analog of luteinizing hormone releasing factor. The drug has been used since 1981 in Japan to treat various types of reproductive failure in cattle.
Class:
PROTEIN
Status:
Investigational
Source:
NCT04716231: Phase 3 Interventional Recruiting IgA Nephropathy
(2023)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03257033: Phase 3 Interventional Recruiting Locally Advanced Pancreatic Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00001564: Phase 2 Interventional Completed Ewing's Sarcoma
(1996)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00877656: Phase 2/Phase 3 Interventional Completed T Cell Lymphoma
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00352131: Phase 1 Interventional Completed Non-colorectal Cancer
(2005)
Source URL:
Class:
PROTEIN
